As a Principal, Matthew provides strategic counsel to a variety of clients across the life sciences industry. His experience spans a range of therapeutic areas, including oncology, immunology, rare disease, neurology, and infectious disease. He has particular interest working in genetic medicines and other advanced therapies, both in shaping the platform strategy of early-stage companies with innovative technologies and helping to guide larger companies as they determine how to invest in these areas.
Prior to joining ClearView, Matthew received his Ph.D. in Cancer and Stem Cell Biology at the New York University School of Medicine, where his research focused on the role of Wnt signaling and other key signal transduction pathways in tumorigenesis and stem cell maintenance. He received a B.S. in Biological Sciences from Cornell University.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian
Vini De Nadai